Virtual Reality: A New Technological Modality to Deliver Psychotherapyto Hemodialysis Patients with Comorbid Depression
虚拟现实:为患有抑郁症的血液透析患者提供心理治疗的新技术方式
基本信息
- 批准号:10478221
- 负责人:
- 金额:$ 31.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdultAffectBehaviorBiological MarkersChronically IllClinicClinicalCognitive TherapyCommunicationComputer softwareDataDialysis procedureDietary intakeDisease OutcomeDistantDistressEconomic BurdenEmotionalEnd stage renal failureEnvironmentEventEvidence based interventionExerciseEye MovementsGardenalGoalsHandHead MovementsHealthHealth TechnologyHemodialysisHospitalizationImageryImmersionInterventionKidney DiseasesKnowledgeLifeLongevityMaintenanceMedicareMeditationMental DepressionMental HealthMissionModalityMorbidity - disease rateNational Institute of Diabetes and Digestive and Kidney DiseasesOutcomePainPatientsPersonsPopulationPrivatizationProceduresPsychotherapyPublic HealthQuality of lifeRandomizedRandomized Controlled TrialsResearchResourcesRiskSamplingScheduleScienceSelf CareSiteStreamSurvival RateTabletsTaxesTechnologyTelevisionTestingTrainingTravelTreatment ProtocolsVisitVulnerable PopulationsWell in selfacceptability and feasibilityactive controlarmbasebehavioral healthburden of illnesscomorbid depressioncomorbiditycostcost effectivedepressive symptomsdesigndietary adherenceemotional distressevidence baseexperiencegraspgratitudehead mounted displayhospitalization ratesimprovedinnovationliteracymindfulness meditationmortalitynon-compliancenovel therapeutic interventionoptimismpsychologicpsychological distressrecruitreduce symptomsskillstreatment centervirtualvirtual realityvirtual reality environmentweb siteweb-based intervention
项目摘要
PROJECT SUMMARY
Hemodialysis (HD) is a taxing procedure with extensive illness burden and arduous self-care demands. As
such, more than 30% of HD patients experience elevated symptoms of depression—and, research shows that
comorbid depression is associated with adverse kidney disease outcomes, greater risk of hospitalization, and
decreased survival rates. Current interventions to treat depressive symptoms in HD patients are resource
intensive, infrequently administered, and often involve delivery of psychotherapy by highly-trained clinicians via
multiple face-to-face communications. There remains a critical scientific gap for easily disseminatable and
efficient strategies to improve emotional well-being profiles of HD patients in the U.S. and around the world.
Our objective in this small R01 study is to design a virtual reality (VR) platform that fully immerses users into a
fictitious lifelike environment, to deliver our evidence-based positive psychological intervention and to test
whether it improves the emotional well-being of HD patients with comorbid depression. For instance, during the
module focused on mindfulness/meditation, we will use a head-mounted display to fully immerse and transport
HD patients to an open field beside a calming stream where they will engage in a 12-minute guided meditation.
As such, we propose to conduct a 2-arm randomized controlled trial in which HD patients (N=84) will be
randomly assigned to receive either our JovialityTM VR-based positive psychological intervention or an active
control condition (i.e., educational television programming). We hypothesize that chairside delivery of
psychotherapeutic treatment in HD patients using a VR environment will prove feasible and will result in
significant improvements in depressive symptoms, quality of life, and dietary adherence, with lower evident
rates for missed HD sessions and lower hospitalizations—all while serving as a more cost-effective and far-
reaching platform that will greatly expand dissemination. Knowledge gained from completion of the proposed
research will result in the first VR software application to deliver psychotherapy to HD patients, while
simultaneously allowing them to leave the confines of the clinic and virtually travel to distant regions of the
world.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rosalba Hernandez其他文献
Rosalba Hernandez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rosalba Hernandez', 18)}}的其他基金
Virtual Reality: A New Technological Modality to Deliver Psychotherapyto Hemodialysis Patients with Comorbid Depression
虚拟现实:为患有抑郁症的血液透析患者提供心理治疗的新技术方式
- 批准号:
10676316 - 财政年份:2021
- 资助金额:
$ 31.73万 - 项目类别:
Virtual Reality: A New Technological Modality to Deliver Psychotherapyto Hemodialysis Patients with Comorbid Depression
虚拟现实:为患有抑郁症的血液透析患者提供心理治疗的新技术方式
- 批准号:
10280048 - 财政年份:2021
- 资助金额:
$ 31.73万 - 项目类别:
Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease
对有心血管疾病风险的西班牙语裔/拉丁裔成年人进行积极心理学干预
- 批准号:
9973165 - 财政年份:2016
- 资助金额:
$ 31.73万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 31.73万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 31.73万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 31.73万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 31.73万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 31.73万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 31.73万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 31.73万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 31.73万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 31.73万 - 项目类别: